Psych Capital Plc
("Psych Capital" or the "Company")
Result of Annual General Meeting
28 November 2022
The Board of Psych Capital is pleased to announce that at its 2022 Annual General Meeting ("AGM") held today, all resolutions were duly passed.
The Directors of the Company accept responsibility for the contents of this announcement.
For further information, please contact:
Psych Capital Plc
Stephen Murphy, Executive Director
Will Potts, Chief Investment Officer
info@PSYCH.capital
AQSE Growth Market Corporate Adviser
Peterhouse Capital Limited
Tel: +44 (0) 207 469 0930
Guy Miller / Mark Anwyl
About Psych Capital Plc
Psych Capital Plc identifies, funds and aims to support the building of British and European companies across three core pillars: therapeutic treatments, drug development, and data/AI. Its mission is to support a new wave of innovators who are well positioned to challenge the status-quo and revolutionise how society deals with mental health conditions.
Through a network of analysts with deep industry knowledge and capital markets expertise, Psych Capital is focussed on developing a rigorously selected portfolio of industry leading companies at the intersection of psychedelic medicine and technology.
The Psych Platform is a business-to-business media and content platform for the psychedelic science and healthcare industry, and it operates the website, https://psych.global/. The Psych Platform is a global B2B resource for networking, intelligence and insights, servicing the industry through publications, newsletters and engaging events. The Psych Platform has amassed a significant global B2B audience, with over 20,000 subscribers to the platform.
As a business-to-business media and content platform, the Psych Platform also produces the PSYCH Symposium, a premium Live Event series.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.